All Type of News
Designation of bioequivalence testing agencies eyed
The Ministry for Health, Welfare and Family Affairs plans to enact a bill to legislate the government’s designation of bioequivalence testing centers as initially planned, as part of its effort to ensure the reliabili...
Economic effectiveness of medicines to be under debate
With the government’s plan to make public its final assessment of economic effectiveness over antihyperlipidemic agents sooner or later, drug makers are calling for the government to establish more rational standard f...
New KPA chairman starts workKim-ku is starting working as new chairman of the Korea Pharmaceutical Association.
The association held an inauguration ceremony on June 24 with prominent government officia...
|
Medical institutions top 77,783 in first half
The number of Korea’s medical institutions escalated to 77,783 in the first half this year, compared 76,291 in the same period of last year, according to the Health Insurance Review & Assessment Service.
A HIRA off...
Yooyoung launches alprostadil cream
Yooyoung Pharm says it has launched Befar (alprostadil) cream in Korea through its exclusive agreement with the U.S. based Nexmed Co.
Befar has shown a clinical efficacy of up to 83% in patients with varying degree...
Regional KFDA disbandment plan back on track?
Despite the government’ plan to disband six regional agencies of the Korea Food and Drug Administration, rumors are circulating that these agencies will exist with smaller functions and operations.
The six KFDA reg...
Finding growth in generics markets
A number of domestic pharmaceutical firms have managed to increase their sales of generic products through aggressive marketing strategies, despite the local economic slowdown and falling drug prices.
"Much of the ...
Civic group calling for rapid screening process of hyperlipidemic medicines
The Korean Pharmacists for Democratic Society said in a statement that the government would have to shorten its screening process period over the economic effectiveness of hyperlipidemic drugs.
The statement said t...
Lip care market heats up
Three foreign manufacturers – Nivea, Wyeth and Mentholatum - are going all-out to take a bigger share in the domestic lip care market.
The three rivals are adopting more aggressive marketing strategies and action p...
Korea Prime to be listed on main bourse in 2011
SK Securities Co. said Korea Prime Pharmaceutical Co. will go public in 2011 until the company meets the requirements for listing.
The company will be listed on the main bourse through the initial public offerings,...
